Fulcrum Therapeutics Inc (FULC)
3.315
+0.06
(+1.69%)
USD |
NASDAQ |
Nov 05, 16:00
3.315
0.00 (0.00%)
After-Hours: 16:19
Fulcrum Therapeutics Free Cash Flow: -12.62M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -12.62M |
| March 31, 2024 | -92.50M |
| December 31, 2023 | -91.47M |
| September 30, 2023 | -88.05M |
| June 30, 2023 | -93.24M |
| March 31, 2023 | -100.95M |
| December 31, 2022 | -99.01M |
| September 30, 2022 | -101.58M |
| June 30, 2022 | -96.35M |
| March 31, 2022 | -86.06M |
| December 31, 2021 | -80.19M |
| September 30, 2021 | -78.11M |
| Date | Value |
|---|---|
| June 30, 2021 | -59.77M |
| March 31, 2021 | -55.71M |
| December 31, 2020 | -55.00M |
| September 30, 2020 | -39.30M |
| June 30, 2020 | -47.94M |
| March 31, 2020 | -45.90M |
| December 31, 2019 | -40.34M |
| September 30, 2019 | -45.60M |
| June 30, 2019 | -37.42M |
| March 31, 2019 | -34.34M |
| December 31, 2018 | -31.54M |
Free Cash Flow Range, Past 5 Years
-101.58M
Minimum
Sep 2022
-12.62M
Maximum
Jun 2024
-71.79M
Average
-80.19M
Median
Dec 2021
Free Cash Flow Benchmarks
| Bioventus Inc | 8.443M |
| Arcturus Therapeutics Holdings Inc | -71.16M |
| Entrada Therapeutics Inc | -18.50M |
| Johnson & Johnson | 19.02B |
| Insmed Inc | -636.03M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 58.90M |
| Cash from Investing (Quarterly) | -12.51M |
| Cash from Financing (Quarterly) | 0.377M |
| Free Cash Flow Per Share (Quarterly) | 0.9263 |
| Free Cash Flow to Equity (Quarterly) | 58.90M |
| Free Cash Flow Yield | -6.11% |